| Title: | Multivariate GWAS of psychiatric disorders and their cardinal symptoms reveal two dimensions of cross-cutting genetic liabilities |
| Journal: | Cell Genomics |
| Published: | 1 Jun 2022 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/35812988/ |
| DOI: | https://doi.org/10.1016/j.xgen.2022.100140 |
Publication 7580
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Understanding which biological pathways are specific versus general across diagnostic categories and levels of symptom severity is critical to improving nosology and treatment of psychopathology. Here, we combine transdiagnostic and dimensional approaches to genetic discovery for the first time, conducting a novel multivariate genome-wide association study of eight psychiatric symptoms and disorders broadly related to mood disturbance and psychosis. We identify two transdiagnostic genetic liabilities that distinguish between common forms of psychopathology versus rarer forms of serious mental illness. Biological annotation revealed divergent genetic architectures that differentially implicated prenatal neurodevelopment and neuronal function and regulation. These findings inform psychiatric nosology and biological models of psychopathology, as they suggest that the severity of mood and psychotic symptoms present in serious mental illness may reflect a difference in kind rather than merely in degree.16 Authors
- Travis T. Mallard
- Richard Karlsson Linnér
- Andrew D. Grotzinger
- Sandra Sanchez-Roige
- Jakob Seidlitz
- Aysu Okbay
- Ronald de Vlaming
- S. Fleur W. Meddens
- Bipolar Disorder Working Group of the Psychiatric Genomics Consortium
- Abraham A. Palmer
- Lea K. Davis
- Elliot M. Tucker-Drob
- Kenneth S. Kendler
- Matthew C. Keller
- Philipp D. Koellinger
- K. Paige Harden
Enabling scientific discoveries that improve human health